Awarded Grants

The ODC offers over 50 grant opportunities in 30+ disease areas annually to researchers across the globe, as well as within the Penn and CHOP communities. Since 2011, our grant programs have funded $17.2 million in rare disease research.

See below for a complete list of ODC-awarded grants since 2011. 

Full list of CDKL5 Program of Excellence Awardees

Awarded Grants

Displaying Results 21 - 30 of 175

Awardee Project Title Institution Grant Amount Funding Year
Mara Riminucci, MD, PhD Exploring the therapeutic potential of RANKL inhibition in Fibrous Dysplasia of bone: studies on murine transgenic models of the disease Sapienza University of Rome MDBR - Fibrous Dysplasia/McCune Albright Syndrome $53,614 2018
J. Brandon Dixon, PhD Tissue engineered lymphatic malformation on a chip for screening therapeutics Georgia Institute of Technology MDBR - Generalized Lymphatic Anomaly (lymphangiomatosis) & Gorham-Stout Disease $80,185 2018
Umrao Monani, PhD Exploring a novel means of regulating Glut1 expression, and its therapeutic implications Columbia University Medical Center MDBR - Glucose Transporter Deficiency Syndrome $48,918 2018
David Kwiatkowski, MD, PhD Targeting transcription in LAM Brigham and Women's Hospital, Harvard Medical School MDBR - Lymphangioleiomyomatosis $50,060 2018
Jane Yu, PhD The impact of estrogen-promoted extracellular matrix-degrading programs on LAM progression University of Cincinnati College of Medicine MDBR - Lymphangioleiomyomatosis $50,060 2018
Albert Misko, MD, PhD Quantitative assessment of visual engagement in mucolipidosis type IV Massachusetts General Hospital MDBR - Mucolipidosis $71,939 2018
Patricia Dickson, MD Novel alpha-glucosaminidase for Sanfilippo C syndrome Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center MDBR - Mucopolysaccharidoses $59,449 2018
Emyr Lloyd-Evans, D.Phil A humanised Drosophila melanogaster model of MPSIIIb to rapidly study central nervous system efficacy of combined chaperone and substrate reduction therapy Cardiff University MDBR - Mucopolysaccharidoses $59,449 2018
Nina Pipalia, PhD Targeting molecular chaperone HSP90 to treat NPC1 disease Weill Cornell Medical College MDBR - Niemann Pick Type C $49,645 2018
Dolan Sondhi, PhD AAVrh.10-mediated Npc2 Gene transfer for the treatment of Npc2 Deficient Niemann-Pick disease Weill Cornell Medicine MDBR - Niemann Pick Type C $49,645 2018
1 2 3 4 5 6 18